The company continues to operate without revenue while reporting a $2.6 million operating loss in 2025Q3, reflecting the structural costs of its ongoing search for a target.
| Sales/Revenue | 0 | - | - |
| Revenue Growth % | - | - | - |
| Cost of Goods Sold | 0 | - | - |
| COGS % of Revenue | - | - | - |
| Gross Profit | 0 | 0 | 0 |
| Gross Margin % | - | - | - |
| Gross Profit Growth % | - | - | - |
| Operating Expenses | 3.22M | 3.86M | 251.14K |
| OpEx % of Revenue | - | - | - |
| Selling, General & Admin | 2.97M | 3.86M | 502.29K |
| SG&A % of Revenue | - | - | - |
| Research & Development | 0 | - | - |
| R&D % of Revenue | - | - | - |
| Other Operating Expenses | 0 | - | - |
| Operating Income | -3.22M | -3.86M | -502.29K |
| Operating Margin % | - | - | - |
| Operating Income Growth % | - | -667.93% | - |
| EBITDA | -3.22M | -3.86M | 1.52M |
| EBITDA Margin % | - | - | - |
| EBITDA Growth % | - | -353.82% | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 |
| EBIT | -3.22M | 0 | 1.52M |
| Net Interest Income | 7.14M | 0 | 1.77M |
| Interest Income | 7.14M | 0 | 1.77M |
| Interest Expense | 0 | 0 | 0 |
| Other Income/Expense | 0 | - | - |
| Pretax Income | 3.91M | 6.01M | 3.04M |
| Pretax Margin % | - | - | - |
| Income Tax | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% |
| Net Income | 3.91M | 6.01M | 3.04M |
| Net Margin % | - | - | - |
| Net Income Growth % | - | 97.69% | - |
| Net Income (Continuing) | 3.91M | 6.01M | 3.04M |
| Discontinued Operations | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| EPS (Diluted) | 0.16 | 0.24 | 0.09 |
| EPS Growth % | - | 166.67% | - |
| EPS (Basic) | - | 0.24 | 0.09 |
| Diluted Shares Outstanding | 25M | 25.43M | 15.79M |
| Basic Shares Outstanding | 25M | 25.43M | 15.79M |
| Dividend Payout Ratio | - | - | - |
Liquidation and deal failure
As indicated by the most recent quarterly filings, BACQ reported a significant surge in SG&A expenses to $2.6 million in 2025Q3, reflecting the heightened operational costs associated with the company's ongoing search for a suitable business combination within the competitive TMT sector landscape.
The sharp increase in SG&A from negligible levels in previous periods suggests that the company is intensifying its due diligence and professional service engagements. Investors should monitor whether this spending trajectory is sustainable given the limited cash reserves, as excessive search costs may erode the capital available for the eventual target.
Based on the provided financial statements, BACQ's reported net income of $83.7K in 2025Q3 appears disconnected from its $2.6 million operating loss, suggesting that non-operating items, likely related to warrant liability fair value adjustments, are significantly distorting the company's true underlying financial performance.
Analysts should exercise caution when interpreting net income figures for this vehicle, as these non-cash accounting adjustments do not reflect the actual cash burn of the business. The divergence between operating losses and net income highlights the necessity of focusing on cash-based metrics to assess the viability of the SPAC's remaining runway.
According to the historical income statement data, BACQ continues to operate without revenue, resulting in a persistent negative operating margin that reflects the structural reality of a shell company awaiting a definitive business combination to initiate its operational and financial scaling phase.
The absence of revenue means that the company lacks the ability to leverage its cost base, leaving it entirely dependent on external capital or trust interest to fund its administrative overhead. Until a merger is finalized, the company will remain in a state of structural operating inefficiency by design.
With reported cash and equivalents of only $703,596 as noted in recent disclosures, the company faces a precarious financial position that may force management into a suboptimal business combination to avoid the looming liquidation deadline and the exhaustion of its remaining operating capital.
This limited liquidity creates a potential conflict of interest where the pressure to close a deal may outweigh the quality of the target identified. Investors should be wary that the current cash position may necessitate dilutive financing or a rushed transaction, which could negatively impact long-term shareholder value.
Quick answers to the most common questions about buying BACQ stock.
Inflection Point Acquisition Corp. IV (BACQ) is profitable, generating $6.0M in net income for the fiscal year ending 2025.